Skip to content
Operation Infinite Justice – Lifestyle
Author:
Trogenix
Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma
May 28, 2026
Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model
April 8, 2026